Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3′-UTR

Brain Research

Volumn 1120, Issue 1, 2006, Pages 161-171

  Novak, Gabriela ^a   Tallerico, Teresa ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

2p14 p13; CAA TATC 3 UTR polymorphism; Depression; Gene expression; mRNA degradation; Nogo A, B, C; Real time quantitative PCR; RTN4; Schizophrenia; Splice variant

Indexed keywords

ISOPROTEIN; PROTEIN NOGO; PROTEIN NOGO A; PROTEIN NOGO B; PROTEIN NOGO C; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ACCURACY; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FRONTAL CORTEX; GENE INSERTION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; GROUPS BY AGE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; UPREGULATION;

3' UNTRANSLATED REGIONS; ADULT; BIPOLAR DISORDER; DEPRESSION; DNA, COMPLEMENTARY; FEMALE; FRONTAL LOBE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MYELIN PROTEINS; POLYMORPHISM, GENETIC; POSTMORTEM CHANGES; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 33750459720     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.08.071     Document Type: Article

References (55)

1. Akbarian S., Kim J.J., Potkin S.G., Hetrick W.P., Bunney Jr. W.E., and Jones E.G. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch. Gen. Psychiatry 53 (1996) 425-436
2. American Psychiatric Acevedo L., Yu J., Erdjument-Bromage H., Miao R.Q., Kim J.E., Fulton D., Tempst P., Strittmatter S.M., and Sessa W.C. A new role for Nogo as a regulator of vascular remodeling. Nat. Med. 10 (2004) 382-388
3. Association A.P. Diagnostic and Statistical Manual of Mental Disorders (1994), American Psychiatric Association, Washington, DC
4. Ausubel, F.M., 1987. Current protocols in molecular biology. Brooklyn, N. Y. Media, Pa.: Greene Publishing Associates; J. Wiley, order fulfillment. 2 v. (loose-leaf) p.
5. Barrachina M., Castano E., and Ferrer I. TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue. Neurochem. Int. 49 (2006) 276-284
6. Bassett A.S., Hodgkinson K., Chow E.W., Correia S., Scutt L.E., and Weksberg R. 22q11 deletion syndrome in adults with schizophrenia. Am. J. Med. Genet. 81 (1998) 328-337
7. Buffo A., Zagrebelsky M., Huber A.B., Skerra A., Schwab M.E., Strata P., and Rossi F. Application of neutralizing antibodies against NI-35/250 myelin-associated neurite growth inhibitory proteins to the adult rat cerebellum induces sprouting of uninjured Purkinje cell axons. J. Neurosci. 20 (2000) 2275-2286
8. Bunney W.E., and Bunney B.G. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res. Brain Res. Rev. 31 (2000) 138-146
9. Chen H., Bernstein B.W., and Bamburg J.R. Regulating actin-filament dynamics in vivo. Trends Biochem. Sci. 25 (2000) 19-23
10. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., and Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403 (2000) 434-439
11. Chiou S.H., Chen S.J., Peng C.H., Chang Y.L., Ku H.H., Hsu W.M., Ho L.L., and Lee C.H. Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell. Biochem. Biophys. Res. Commun. 343 (2006) 391-400
12. Conne B., Stutz A., and Vassalli J.D. The 3′ untranslated region of messenger RNA: a molecular 'hotspot' for pathology?. Nat. Med. 6 (2000) 637-641
13. Coon H., Myles-Worsley M., Tiobech J., Hoff M., Rosenthal J., Bennett P., Reimherr F., Wender P., Dale P., Polloi A., and Byerley W. Evidence for a chromosome 2p13-14 schizophrenia susceptibility locus in families from Palau, Micronesia. Mol. Psychiatry 3 (1998) 521-527
14. Dupuis L., Gonzalez de Aguilar J.L., di Scala F., Rene F., de Tapia M., Pradat P.F., Lacomblez L., Seihlan D., Prinjha R., Walsh F.S., Meininger V., and Loeffler J.P. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiol. Dis. 10 (2002) 358-365
15. Feinberg I. Cortical pruning and the development of schizophrenia. Schizophr. Bull. 16 (1990) 567-570
16. Fossati P., Radtchenko A., and Boyer P. Neuroplasticity: from MRI to depressive symptoms. Eur. Neuropsychopharmacol. 14 Suppl. 5 (2004) S503-S510
17. Fournier A.E., GrandPre T., and Strittmatter S.M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409 (2001) 341-346
18. Goldman-Rakic P.S., and Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr. Bull. 23 (1997) 437-458
19. GrandPre T., Nakamura F., Vartanian T., and Strittmatter S.M. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403 (2000) 439-444
20. Gray N.K., and Wickens M. Control of translation initiation in animals. Annu. Rev. Cell Dev. Biol. 14 (1998) 399-458
21. Hayley S., Poulter M.O., Merali Z., and Anisman H. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity. Neuroscience 135 (2005) 659-678
22. Hens J., Nuydens R., Geerts H., Senden N.H., Van de Ven W.J., Roebroek A.J., van de Velde H.J., Ramaekers F.C., and Broers J.L. Neuronal differentiation is accompanied by NSP-C expression. Cell Tissue Res. 292 (1998) 229-237
23. Hickmott P.W., and Constantine-Paton M. Experimental down-regulation of the NMDA channel associated with synapse pruning. J. Neurophysiol. 78 (1997) 1096-1107
24. Hu F., Liu B.P., Budel S., Liao J., Chin J., Fournier A., and Strittmatter S.M. Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist. J. Neurosci. 25 (2005) 5298-5304
25. Huber A.B., Weinmann O., Brosamle C., Oertle T., and Schwab M.E. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J. Neurosci. 22 (2002) 3553-3567
26. J.R. Geigy A.G., and Diem K. Scientific Tables (1959), Geigy Pharmaceuticals, Ardsley, N.Y. 778 pp.
27. Jokic N., Gonzalez de Aguilar J.L., Pradat P.F., Dupuis L., Echaniz-Laguna A., Muller A., Dubourg O., Seilhean D., Hauw J.J., Loeffler J.P., and Meininger V. Nogo expression in muscle correlates with amyotrophic lateral sclerosis severity. Ann. Neurol. 57 (2005) 553-556
28. Jonas E.A., Hoit D., Hickman J.A., Brandt T.A., Polster B.M., Fannjiang Y., McCarthy E., Montanez M.K., Hardwick J.M., and Kaczmarek L.K. Modulation of synaptic transmission by the BCL-2 family protein BCL-xL. J. Neurosci. 23 (2003) 8423-8431
29. Josephson A., Widenfalk J., Widmer H.W., Olson L., and Spenger C. NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp. Neurol. 169 (2001) 319-328
30. Josephson A., Widenfalk J., Widmer H.W., Olson L., and Spenger C. NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp. Neurol. 169 (2001) 319-328
31. Karayiorgou M., Morris M.A., Morrow B., Shprintzen R.J., Goldberg R., Borrow J., Gos A., Nestadt G., Wolyniec P.S., Lasseter V.K., et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 7612-7616
32. Karnezis T., Mandemakers W., McQualter J.L., Zheng B., Ho P.P., Jordan K.A., Murray B.M., Barres B., Tessier-Lavigne M., and Bernard C.C. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat. Neurosci. 7 (2004) 736-744
33. Keshavan M.S., Anderson S., and Pettegrew J.W. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J. Psychiatr. Res. 28 (1994) 239-265
34. Kiebler M.A., and DesGroseillers L. Molecular insights into mRNA transport and local translation in the mammalian nervous system. Neuron 25 (2000) 19-28
35. Meyer S., Temme C., and Wahle E. Messenger RNA turnover in eukaryotes: pathways and enzymes. Crit. Rev. Biochem. Mol. Biol. 39 (2004) 197-216
36. Mitchell P., and Tollervey D. mRNA turnover. Curr. Opin. Cell Biol. 13 (2001) 320-325
37. Novak G., Kim D., Seeman P., and Tallerico T. Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Brain Res. Mol. Brain Res. 107 (2002) 183-189
38. Oertle T., Huber C., van der Putten H., and Schwab M.E. Genomic structure and functional characterisation of the promoters of human and mouse nogo/rtn4. J. Mol. Biol. 325 (2003) 299-323
39. Oertle T., Klinger M., Stuermer C.A., and Schwab M.E. A reticular rhapsody: phylogenic evolution and nomenclature of the RTN/Nogo gene family. FASEB J. 17 (2003) 1238-1247
40. Oertle T., van der Haar M.E., Bandtlow C.E., Robeva A., Burfeind P., Buss A., Huber A.B., Simonen M., Schnell L., Brosamle C., Kaupmann K., Vallon R., and Schwab M.E. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J. Neurosci. 23 (2003) 5393-5406
41. Prinjha R., Moore S.E., Vinson M., Blake S., Morrow R., Christie G., Michalovich D., Simmons D.L., and Walsh F.S. Inhibitor of neurite outgrowth in humans. Nature 403 (2000) 383-384
42. Prinjha R., Moore S.E., Vinson M., Blake S., Morrow R., Christie G., Michalovich D., Simmons D.L., and Walsh F.S. Inhibitor of neurite outgrowth in humans. (Letter) Nature 403 (2000) 383-384
43. Qi B., Qi Y., Watari A., Yoshioka N., Inoue H., Minemoto Y., Yamashita K., Sasagawa T., and Yutsudo M. Pro-apoptotic ASY/Nogo-B protein associates with ASYIP. J. Cell. Physiol. 196 (2003) 312-318
44. Reindl M., Khantane S., Ehling R., Schanda K., Lutterotti A., Brinkhoff C., Oertle T., Schwab M.E., Deisenhammer F., Berger T., and Bandtlow C.E. Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders. J. Neuroimmunol. 145 (2003) 139-147
45. Seeman P., and Tallerico T. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am. J. Psychiatry 156 (1999) 876-884
46. Shaw S.H., Kelly M., Smith A.B., Shields G., Hopkins P.J., Loftus J., Laval S.H., Vita A., De Hert M., Cardon L.R., Crow T.J., Sherrington R., and DeLisi L.E. A genome-wide search for schizophrenia susceptibility genes. Am. J. Med. Genet. 81 (1998) 364-376
47. Skaper S.D., Moore S.E., and Walsh F.S. Cell signalling cascades regulating neuronal growth-promoting and inhibitory cues. Prog. Neurobiol. 65 (2001) 593-608
48. Straub R.E., MacLean C.J., Ma Y., Webb B.T., Myakishev M.V., Harris-Kerr C., Wormley B., Sadek H., Kadambi B., O'Neill F.A., Walsh D., and Kendler K.S. Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes. Mol. Psychiatry 7 (2002) 542-559
49. Suddath R.L., Christison G.W., Torrey E.F., Casanova M.F., and Weinberger D.R. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N. Engl. J. Med. 322 (1990) 789-794
50. Tagami S., Eguchi Y., Kinoshita M., Takeda M., and Tsujimoto Y. A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. Oncogene 19 (2000) 5736-5746
51. Torrey E.F., Webster M., Knable M., Johnston N., and Yolken R.H. The Stanley foundation brain collection and neuropathology consortium. Schizophr. Res. 44 (2000) 151-155
52. Yan R., Shi Q., Hu X., and Zhou X. Reticulon proteins: emerging players in neurodegenerative diseases. Cell. Mol. Life Sci. 63 (2006) 877-889
53. Yang J., Yu L., Bi A.D., and Zhao S.Y. Assignment of the human reticulon 4 gene (RTN4) to chromosome 2p14→2p13 by radiation hybrid mapping. Cytogenet. Cell Genet. 88 (2000) 101-102
54. Zagrebelsky M., Buffo A., Skerra A., Schwab M.E., Strata P., and Rossi F. Retrograde regulation of growth-associated gene expression in adult rat Purkinje cells by myelin-associated neurite growth inhibitory proteins. J. Neurosci. 18 (1998) 7912-7929
55. Zubenko G.S., Maher B.S., Hughes III H.B., Zubenko W.N., Scott Stiffler J., and Marazita M.L. Genome-wide linkage survey for genetic loci that affect the risk of suicide attempts in families with recurrent, early-onset, major depression. Am. J. Med. Genet., Part B Neuropsychiatr. Genet. 129 (2004) 47-54